tirzepatide adolescent Once Weekly in Children and Adolescents with Type 2 Diabetes (SURPASS-Peds). The New England Journal of Medicine. 2024;391:XXX–XXX. doi:10.1056/NEJMoa2400938 A Study of Tirzepatide (LY3298176)

What the Research Shows The approval was based on impressive results from the SURMOUNT-OSA clinical trials involving 469 adults: For people NOT using CPAP machines: Tirzepatide reduced breathing interruptions by 25 events per hour Placebo only reduced interruptions by 5 events per hour 42% achieved remission or mild symptoms after one year For people USING CPAP machines: Tirzepatide reduced breathing interruptions by 29 events per hour Placebo only reduced interruptions by 6 events per hour 50% achieved remission or mild symptoms after one year Beyond Sleep Apnea While sleep apnea research is most advanced, early evidence suggests GLP-1 medications may help with other sleep problems too: Reduced insomnia symptoms Less tossing and turning at night Improved deep sleep quality Better daytime energy levels Who Can Benefit From GLP-1 Therapy for Sleep

Monoamine Oxidase A Gene Polymorphisms and Enzyme Activity Associated with Risk of Gout in Taiwan Aborigines. Human Genetics, vol

Call Now!

And knowing exactly how many units corresponds to your dose at your specific concentration is the only way to ensure accuracy every single week